Annual CFO
$142.58 M
+$154.13 M+1334.16%
December 31, 2023
Summary
- As of February 7, 2025, EVH annual cash flow from operations is $142.58 million, with the most recent change of +$154.13 million (+1334.16%) on December 31, 2023.
- During the last 3 years, EVH annual CFO has risen by +$158.81 million (+978.78%).
- EVH annual CFO is now at all-time high.
Performance
EVH Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
$18.67 M
-$2.75 M-12.83%
September 30, 2024
Summary
- As of February 7, 2025, EVH quarterly cash flow from operations is $18.67 million, with the most recent change of -$2.75 million (-12.83%) on September 30, 2024.
- Over the past year, EVH quarterly CFO has dropped by -$70.71 million (-79.11%).
- EVH quarterly CFO is now -79.11% below its all-time high of $89.38 million, reached on December 31, 2023.
Performance
EVH Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
$134.38 M
-$41.85 M-23.75%
September 30, 2024
Summary
- As of February 7, 2025, EVH TTM cash flow from operations is $134.38 million, with the most recent change of -$41.85 million (-23.75%) on September 30, 2024.
- Over the past year, EVH TTM CFO has dropped by -$8.21 million (-5.75%).
- EVH TTM CFO is now -23.75% below its all-time high of $176.23 million, reached on June 30, 2024.
Performance
EVH TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
EVH Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +1334.2% | -79.1% | -5.8% |
3 y3 years | +978.8% | -72.0% | +246.8% |
5 y5 years | +790.4% | -72.0% | +246.8% |
EVH Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +1334.2% | -79.1% | +132.5% | -23.8% | +1263.1% |
5 y | 5-year | at high | +434.4% | -79.1% | +132.5% | -23.8% | +227.1% |
alltime | all time | at high | +434.4% | -79.1% | +132.5% | -23.8% | +227.1% |
Evolent Health Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $18.67 M(-12.8%) | $134.38 M(-23.7%) |
Jun 2024 | - | $21.42 M(+336.3%) | $176.23 M(+13.4%) |
Mar 2024 | - | $4.91 M(-94.5%) | $155.47 M(+9.0%) |
Dec 2023 | $142.58 M(-1334.2%) | $89.38 M(+47.7%) | $142.58 M(+60.4%) |
Sep 2023 | - | $60.52 M(+9154.0%) | $88.90 M(+256.9%) |
Jun 2023 | - | $654.00 K(-108.2%) | $24.91 M(-34.3%) |
Mar 2023 | - | -$7.97 M(-122.3%) | $37.91 M(-428.2%) |
Dec 2022 | -$11.55 M(-129.8%) | $35.70 M(-1128.7%) | -$11.55 M(-159.5%) |
Sep 2022 | - | -$3.47 M(-125.4%) | $19.41 M(-71.2%) |
Jun 2022 | - | $13.66 M(-123.8%) | $67.38 M(+128.7%) |
Mar 2022 | - | -$57.44 M(-186.2%) | $29.47 M(-23.9%) |
Dec 2021 | $38.75 M(-338.8%) | $66.66 M(+49.8%) | $38.75 M(-195.1%) |
Sep 2021 | - | $44.50 M(-283.5%) | -$40.76 M(-61.5%) |
Jun 2021 | - | -$24.25 M(-49.7%) | -$105.76 M(+141.2%) |
Mar 2021 | - | -$48.16 M(+274.8%) | -$43.85 M(+170.2%) |
Dec 2020 | -$16.23 M(-62.0%) | -$12.85 M(-37.3%) | -$16.23 M(-265.3%) |
Sep 2020 | - | -$20.50 M(-154.4%) | $9.81 M(-28.5%) |
Jun 2020 | - | $37.67 M(-283.4%) | $13.72 M(-136.6%) |
Mar 2020 | - | -$20.54 M(-255.8%) | -$37.48 M(-12.1%) |
Dec 2019 | -$42.65 M | $13.19 M(-179.5%) | -$42.65 M(-47.2%) |
Sep 2019 | - | -$16.59 M(+22.6%) | -$80.80 M(+92.9%) |
Jun 2019 | - | -$13.53 M(-47.4%) | -$41.89 M(+93.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2019 | - | -$25.71 M(+3.0%) | -$21.66 M(+4.9%) |
Dec 2018 | -$20.65 M(-26.1%) | -$24.97 M(-211.9%) | -$20.65 M(-299.5%) |
Sep 2018 | - | $22.32 M(+233.1%) | $10.35 M(-227.0%) |
Jun 2018 | - | $6.70 M(-127.1%) | -$8.15 M(-54.5%) |
Mar 2018 | - | -$24.70 M(-509.4%) | -$17.90 M(-36.0%) |
Dec 2017 | -$27.96 M(-21.3%) | $6.04 M(+58.0%) | -$27.96 M(-49.6%) |
Sep 2017 | - | $3.82 M(-225.3%) | -$55.50 M(+8.0%) |
Jun 2017 | - | -$3.05 M(-91.2%) | -$51.40 M(+3.9%) |
Mar 2017 | - | -$34.77 M(+61.7%) | -$49.47 M(+39.3%) |
Dec 2016 | -$35.51 M(+92.3%) | -$21.50 M(-371.8%) | -$35.51 M(+74.8%) |
Sep 2016 | - | $7.91 M(-810.3%) | -$20.32 M(-41.2%) |
Jun 2016 | - | -$1.11 M(-94.6%) | -$34.58 M(-12.0%) |
Mar 2016 | - | -$20.80 M(+229.6%) | -$39.27 M(+112.6%) |
Dec 2015 | -$18.47 M(<-9900.0%) | -$6.31 M(-0.6%) | -$18.47 M(+51.9%) |
Sep 2015 | - | -$6.35 M(+9.3%) | -$12.16 M(+109.3%) |
Jun 2015 | - | -$5.81 M(<-9900.0%) | -$5.81 M(-253.9%) |
Mar 2015 | - | $0.00(0.0%) | $3.77 M(>+9900.0%) |
Dec 2014 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2014 | - | $0.00(-100.0%) | $0.00(0.0%) |
Jun 2014 | - | $3.77 M(-200.0%) | $0.00(-100.0%) |
Mar 2014 | - | -$3.77 M | -$3.77 M |
Dec 2013 | -$13.63 M | - | - |
FAQ
- What is Evolent Health annual cash flow from operations?
- What is the all time high annual CFO for Evolent Health?
- What is Evolent Health annual CFO year-on-year change?
- What is Evolent Health quarterly cash flow from operations?
- What is the all time high quarterly CFO for Evolent Health?
- What is Evolent Health quarterly CFO year-on-year change?
- What is Evolent Health TTM cash flow from operations?
- What is the all time high TTM CFO for Evolent Health?
- What is Evolent Health TTM CFO year-on-year change?
What is Evolent Health annual cash flow from operations?
The current annual CFO of EVH is $142.58 M
What is the all time high annual CFO for Evolent Health?
Evolent Health all-time high annual cash flow from operations is $142.58 M
What is Evolent Health annual CFO year-on-year change?
Over the past year, EVH annual cash flow from operations has changed by +$154.13 M (+1334.16%)
What is Evolent Health quarterly cash flow from operations?
The current quarterly CFO of EVH is $18.67 M
What is the all time high quarterly CFO for Evolent Health?
Evolent Health all-time high quarterly cash flow from operations is $89.38 M
What is Evolent Health quarterly CFO year-on-year change?
Over the past year, EVH quarterly cash flow from operations has changed by -$70.71 M (-79.11%)
What is Evolent Health TTM cash flow from operations?
The current TTM CFO of EVH is $134.38 M
What is the all time high TTM CFO for Evolent Health?
Evolent Health all-time high TTM cash flow from operations is $176.23 M
What is Evolent Health TTM CFO year-on-year change?
Over the past year, EVH TTM cash flow from operations has changed by -$8.21 M (-5.75%)